MEDIFAST is a personal services business based in the US. MEDIFAST shares (MED) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $18.14 – a decrease of 5.32% over the previous week. MEDIFAST employs 634 staff and has a trailing 12-month revenue of around $674.5 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $18.14 |
|---|---|
| 52-week range | $17.07 - $76.42 |
| 50-day moving average | $18.58 |
| 200-day moving average | $26.35 |
| Wall St. target price | $16.50 |
| PE ratio | 27.2836 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.67 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $18.28 from 2024-11-14
| 1 week (2024-11-08) | -4.59% |
|---|---|
| 1 month (2024-10-16) | 1.67% |
| 3 months (2024-08-16) | -0.27% |
| 6 months (2024-05-16) | -27.92% |
| 1 year (2023-11-16) | -72.45% |
|---|---|
| 2 years (2022-11-16) | -83.47% |
| 3 years (2021-11-16) | 206.4643 |
| 5 years (2019-11-15) | 64.7452 |
Valuing MEDIFAST stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDIFAST's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MEDIFAST's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, MEDIFAST shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
MEDIFAST's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDIFAST's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MEDIFAST's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $27 million.
The EBITDA is a measure of a MEDIFAST's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $674.5 million |
|---|---|
| Operating margin TTM | 1.5% |
| Gross profit TTM | $1.1 billion |
| Return on assets TTM | 4.77% |
| Return on equity TTM | 3.66% |
| Profit margin | 1.09% |
| Book value | $19.47 |
| Market Capitalization | $199.9 million |
TTM: trailing 12 months
We're not expecting MEDIFAST to pay a dividend over the next 12 months.
Over the last 12 months, MEDIFAST's shares have ranged in value from as little as $17.0692 up to $76.42. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDIFAST's is 1.158. This would suggest that MEDIFAST's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Medifast, Inc. , through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. .
The $500 Axos Bank bonus is now expired, but you can still earn $50 per qualifying referral, plus up to $400 with a new business account.
Find out if Priority Plus Financial’s advertised loans are worth it or just a sales hook.
Where to get a holiday loan in 2024 and whether it makes sense for you.
Modak has no monthly fee, but it’s slim on features. Greenlight starts at $5.99 but is a value for big families.
Get the capital your business needs to grow with repayments that adapt to your revenue.
We’ve compared the best cash advance apps for quick cash — find the right one for your needs.
A review of Beyond Finance, a company that offers debt settlement and consolidation loans.
1. Make a budget 2. Create a savings plan 3. Automate savings 4. Pay yourself first 5. Use a high-yield account 6. Do a savings challenge…
To save $10K: 1. Automate savings 2. Invest 3. Budget 4. Open a high-yield savings account 5. Cut down on spending 6. Pay off debt…
A review of Arrowhead Advance, a tribal lender that charges interest rates up to 830% and has numerous bad reviews.